GlassScriptPhysician profile
Lance Michael Tigyer
NPI 1558320408
$29,072.12
in general payments reported to CMS, 2019-2025
24 companies · $1,891 in 2025
The $1,891 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $1,273 · 2021: $1,905 · 2022: $5,485 · 2023: $789 · 2024: $797 · 2025: $1,891.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,031 · Gift: $447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,030.68 |
| Gift | $446.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $16,530.21 | 2019-2024 | |
| Ctl Medical Corporation | $6,168.37 | 2019-2025 | Spinal, Raphael Pedicle Screw System |
| Boston Scientific Corporation | $1,637.47 | 2020-2025 | Artisan, Intracept, General - Pain Management |
| Centinel Spine, LLC | $1,593.19 | 2019 | |
| Integrity Implants INC. | $1,051.71 | 2022 | |
| Abbott Laboratories | $974.67 | 2021-2025 | Proclaim, Eterna |
| Nevro Corp. | $207.33 | 2021-2024 | Senza |
| Camber Spine Technologies LLC | $155.91 | 2019 | |
| Zimvie INC. | $147.64 | 2024 | |
| Elevation Spine, INC. | $116.97 | 2025 | |
| Medtronic, INC. | $76.87 | 2022 | |
| Globus Medical, INC. | $75.52 | 2025 | Senza, Vyrsa V1 |
| Saluda Medical Americas, INC. | $71.37 | 2024-2025 | Evoke |
| Curonix LLC | $50.64 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic USA, INC. | $35.98 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $30.72 | 2024 | Anastoclip Gc 8cm (Medium) |
| Depuy Synthes Sales INC. | $29.47 | 2024 | Orthovisc, Monovisc |
| Convatec INC. | $23.61 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $22.68 | 2025 | |
| Amgen INC. | $21.18 | 2024 | Evenity, Prolia |
| Zimmer Biomet Holdings, INC. | $19.36 | 2023 | Mymobility Platform, Persona |
| Vertos Medical, INC. | $17.61 | 2020 | |
| Pacira Therapeutics, INC. | $13.64 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$150,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Tigyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.